
S1120 Sodium-Glucose Co-Transporter 2 Inhibitors: Promising Results in Transaminase Reduction for the Treatment of Non-Alcoholic Fatty Liver Disease
Author(s) -
Joseph Gabriel,
Laith Al Momani,
Harika Balagoni,
Mohammad Alomari,
Chakradhar Reddy
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000706528.23771.3f
Subject(s) - medicine , fatty liver , placebo , gastroenterology , liver transplantation , diabetes mellitus , liver disease , transaminase , meta analysis , randomized controlled trial , alanine transaminase , disease , transplantation , endocrinology , enzyme , pathology , biochemistry , chemistry , alternative medicine